logo

TOI

The Oncology·NASDAQ
--
--(--)
--
--(--)

TOI fundamentals

The Oncology (TOI) expects to report earnings on Mar 12, 2026, with estimated revenue of 139.79M (YoY +39.41%), and EPS at -0.09 (YoY +35.71%).
Revenue estimate / YoY
139.79M
+39.41%
EPS estimate / YoY
-0.09
+35.71%
Report date
Mar 12, 2026
Earnings Call
5:00 PM on Mar 12, 2026
Meeting link.
EPS
Revenue

Revenue & Expenses

TOI has released its 2025 Q3 earnings report, with revenue of 136.56M, reflecting a YoY change of 36.70%, and net profit of -16.50M, showing a YoY change of -2.43%. The Sankey diagram below clearly presents TOI's revenue sources and cost distribution.

Key Indicators

The Oncology (TOI) key financial stats and ratios, covering profitability, financial health, and leverage.
The Oncology (TOI)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
The Oncology (TOI)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
The Oncology (TOI)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does The Oncology (TOI) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track The Oncology (TOI) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield